Home | Contact Us | Log In
(888) 789-6604
Report Stack
Advanced search
Account Detail 0 items in basket
Order History Total $
Saved Searches View Basket basket
China Heparin Industry Report, 2014-2017
Publication Date Oct 2014
Product Type Report
Pages 88
Single User License help $ 2150.00
Corporate User License help $ 3400.00
 

Reportstack.com does not charge credit card fee, transaction charges, extra tax or VAT on any purchase.

As the world's major heparin API producer and exporter, China boasts enormous raw materials, which provides a strong support for the production of China’s heparin products. In 2013, the live pigs raised in China could manufacture 27.9 trillion units of heparin crude products. And in H1 2014, the live hogs in China may produce 14.09 trillion units of heparin crude products, up 5.6% on a year-on-year basis.

In 2011-2013, affected by the economic downturn in Europe and America, the global heparin preparations market continued to drop, with the sales volume of main heparin preparations brands virtually presenting decline, thus dragging down the exports of China’s heparin products. In 2013, China exported approximately 13.68 trillion units of heparin and its salts, falling 5.9% year on year, and the figure edged down 0.6% from a year earlier to around 9.32 trillion units in Jan.-Aug. 2014.

The major global heparin API suppliers, including Hepalink, Nanjing King-friend, Dongcheng Biochemicals, Qianhong Bio-pharma, and Changshan Biochemical Pharmaceutical, have been among the top 4 heparin exporters in China for many years, together accounting for over 60% of China’s total heparin exports. In response to the impact from international markets, enterprises are stepping up efforts to figure out the solutions, with Hepalink expanding its market share of heparin crude products via M&As overseas. By contrast, the enterprises like Qianhong Bio-pharma, Dongcheng Biochemicals, and Changshan Biochemical Pharmaceutical have accelerated the R&D into and production of low molecular weight heparin preparations. And Nanjing King-friend is aggressively seeking to expand capacity through IPO.

Although the leading heparin enterprises planned to increase capacity and improve the heparin industry chain a few years ago, yet quite a few heparin API projects that had been scheduled to go into operation in 2014 were delayed successively due to depressed market demand or improved technical standards, these projects including Dongcheng Biochemicals’ 32t/a Crude Heparin Sodium Project and Qianhong Bio-pharma’s Heparin API and Preparations Expansion Project.

In terms of the proposed/ongoing projects, however, it is projected that the heparin API in China will achieve an additional capacity of more than 20 trillion units by 2015, when China’s total capacity will exceed 30 trillion units, accounting for roughly 80% of the global demand.

Given that America's economy showed signs of recovery and the European economy did not continue to deteriorate, we foresee that the market size of the global heparin API and preparation market will bounce back in 2014-2017, when China’s heparin industry, heparin API in particular, will see an improved degree of prosperity, thus further releasing new capacity.

China Heparin Industry Report, 2014-2017 mainly deals with the followings:
-Global heparin supply & demand, competitive landscape and forecast, etc.;
-Development, access barriers, supply & demand, competitive landscape, import & export, and development forecast, etc. of China heparin API industry;
-Development, supply & demand, competitive landscape and development forecast, etc. of China heparin preparations industry;
-Operation, Heparin Business, development prospect, etc. of 7 heparin enterprises, including Hepalink, Nanjing King-friend, Qianhong Bio-pharma, Dongcheng Biochemicals, as well as Changshan Biochemical Pharmaceutical.

Table of Contents

1. Overview of Heparin Industry
1.1 Definition and Classification
1.2 Industry Chain

2. Operating Environment of Heparin Industry in China
2.1 Access Barriers
2.1.1 Related Policies
2.1.2 Technical Requirements
2.1.3 Capital Barrier
2.2 Global Market Supply & Demand
2.3 Global Market Competition
2.4 Global Market Forecast
3. Development of Heparin API Industry in China
3.1 Status quo
3.2 Supply & Demand
3.3 Competitive Landscape
3.4 Import & Export
3.4.1 Export
3.4.2 Import
3.5 Prospect and Forecast

4. Development of Heparin Preparation Industry in China
4.1 Market Size
4.2 Low Molecular Heparin Preparation
4.2.1 Low Molecular Weight Heparin Calcium Preparation
4.2.2 Low Molecular Weight Heparin Sodium Preparation
4.3 Unfractionated Heparin Preparation
4.4 Prospect and Forecast

5. Key Heparin Enterprises in China
5.1 Hepalink
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 R&D and Investment
5.1.6 Major Clients
5.1.7 Heparin Business
5.1.8 Prospect and Forecast

5.2 Qianhong Bio-pharma
5.2.1 Profile
5.2.2 Operation
5.2.3 Revenue Structure
5.2.4 Gross Margin
5.2.5 R&D and Investment
5.2.6 Major Clients
5.2.7 Heparin Business
5.2.8 Prospect and Forecast

5.3 Dongcheng Biochemicals
5.3.1 Profile
5.3.2 Operation
5.3.3 Revenue Structure
5.3.4 Gross Margin
5.3.5 R&D and Investment
5.3.6 Major Clients
5.3.7 Heparin Business
5.3.8 Prospect and Forecast

5.4 Changshan Biochemical Pharmaceutical
5.4.1 Profile
5.4.2 Operation
5.4.3 Revenue Structure
5.4.4 Gross Margin
5.4.5 R&D and Investment
5.4.6 Major Clients
5.4.7 Heparin Business
5.4.8 Prospect and Forecast

5.5 Tianjin Chase Sun Pharmaceutical
5.5.1 Profile
5.5.2 Operation
5.5.3 Revenue Structure
5.5.4 Gross Margin
5.5.5 R&D and Investment
5.5.6 Major Clients
5.5.7 Heparin Business
5.5.8 Prospect and Forecast

5.6 Nanjing King-friend
5.6.1 Profile
5.6.2 Operation and Prospect

5.7 Wanbang Biopharmaceuticals
5.7.1 Profile
5.7.2 Development
5.7.3 Operation
5.7.4 Heparin Business

List of Selected Charts

1. Overview of Heparin Industry
1.1 Definition and Classification
1.2 Industry Chain

2. Operating Environment of Heparin Industry in China
2.1 Access Barriers
2.1.1 Related Policies
2.1.2 Technical Requirements
2.1.3 Capital Barrier
2.2 Global Market Supply & Demand
2.3 Global Market Competition
2.4 Global Market Forecast
3. Development of Heparin API Industry in China
3.1 Status quo
3.2 Supply & Demand
3.3 Competitive Landscape
3.4 Import & Export
3.4.1 Export
3.4.2 Import
3.5 Prospect and Forecast

4. Development of Heparin Preparation Industry in China
4.1 Market Size
4.2 Low Molecular Heparin Preparation
4.2.1 Low Molecular Weight Heparin Calcium Preparation
4.2.2 Low Molecular Weight Heparin Sodium Preparation
4.3 Unfractionated Heparin Preparation
4.4 Prospect and Forecast

5. Key Heparin Enterprises in China
5.1 Hepalink
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 R&D and Investment
5.1.6 Major Clients
5.1.7 Heparin Business
5.1.8 Prospect and Forecast

5.2 Qianhong Bio-pharma
5.2.1 Profile
5.2.2 Operation
5.2.3 Revenue Structure
5.2.4 Gross Margin
5.2.5 R&D and Investment
5.2.6 Major Clients
5.2.7 Heparin Business
5.2.8 Prospect and Forecast

5.3 Dongcheng Biochemicals
5.3.1 Profile
5.3.2 Operation
5.3.3 Revenue Structure
5.3.4 Gross Margin
5.3.5 R&D and Investment
5.3.6 Major Clients
5.3.7 Heparin Business
5.3.8 Prospect and Forecast

5.4 Changshan Biochemical Pharmaceutical
5.4.1 Profile
5.4.2 Operation
5.4.3 Revenue Structure
5.4.4 Gross Margin
5.4.5 R&D and Investment
5.4.6 Major Clients
5.4.7 Heparin Business
5.4.8 Prospect and Forecast

5.5 Tianjin Chase Sun Pharmaceutical
5.5.1 Profile
5.5.2 Operation
5.5.3 Revenue Structure
5.5.4 Gross Margin
5.5.5 R&D and Investment
5.5.6 Major Clients
5.5.7 Heparin Business
5.5.8 Prospect and Forecast

5.6 Nanjing King-friend
5.6.1 Profile
5.6.2 Operation and Prospect

5.7 Wanbang Biopharmaceuticals
5.7.1 Profile
5.7.2 Development
5.7.3 Operation
5.7.4 Heparin Business

Title Date Price
2012 Deep Research Report on China Human Albumin Industry
By QYResearch
2012 Deep Research Report on China Human Albumin Industry was professional and depth research report on China Human Albumin industry. This report has firstly introduced Human Albumin definition classi ...Read More
Nov 2012 $2000.00
2013 Deep Research Report on Global and China Human Coagulation Factor Ⅷ Industry
By QYResearch
2013 Deep Research Report on Global and China Human Coagulation Factor Ⅷ Industry is a professional and depth research report on Global and China Human Coagulation Factor Ⅷ industry. This ...Read More
Mar 2013 $2200.00
2014 Deep Research Report on Global and China Glutamate Dehydrogenase Industry
By QYResearch
<2014 Deep Research Report on Global and China Glutamate Dehydrogenase Industry> was professional and depth research report on Global and China Glutamate Dehydrogenase industry. The report first ...Read More
May 2014 $2200.00
2014 Deep Research Report on Global And China Nucleotide Industry
By QYResearch
<2014 Deep Research Report on Global And China Nucleotide Industry> was professional and depth research report on Global and China Nucleotide Industry. The report firstly introduced Nucleotide b ...Read More
Jan 2014 $2200.00
2014 Deep Research Report on Global And China Pectinase Industry
By QYResearch
<2014 Deep Research Report on Global And China Pectinase Industry> was professional and depth research report on Global and China Pectinase industry. The report firstly introduced Pectinase basi ...Read More
Mar 2014 $2200.00
2014 Deep Research Report on Global and China Xylose Industry
By QYResearch
<2014 Deep Research Report on Global and China Xylose Industry> was professional and depth research report on Global and China Xylose industry. The report firstly introduced Xylose basic informa ...Read More
Jun 2014 $2200.00
Argentina Dental Devices Market Outlook to 2018 - CAD/CAM Dental Systems, Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others
By GlobalData
Argentina Dental Devices Market Outlook to 2018 - CAD/CAM Dental Systems, Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersSummaryGlobalData’s new report, ...Read More
Nov 2012 $2500.00
Asia-Pacific Dental Devices Market Outlook to 2018 - CAD/CAM Dental Systems, Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others
By GlobalData
Asia-Pacific Dental Devices Market Outlook to 2018 - CAD/CAM Dental Systems, Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersSummaryGlobalData’s new repor ...Read More
Nov 2012 $3500.00
Australia Dental Devices Market Outlook to 2018 - CAD/CAM Dental Systems, Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and Others
By GlobalData
Australia Dental Devices Market Outlook to 2018 - CAD/CAM Dental Systems, Dental Chairs and Equipment, Dental Implants, Biomaterials and Crowns and Bridges and OthersSummaryGlobalData’s new report, ...Read More
Nov 2012 $2500.00
Austria Dental Devices Market Outlook to 2018 - CAD/CAM Dental Systems, Dental Chairs and Equipment, Dental Implants, Dental Biomaterials, Crowns and Bridges and Others
By GlobalData
Austria Dental Devices Market Outlook to 2018 - CAD/CAM Dental Systems, Dental Chairs and Equipment, Dental Implants, Dental Biomaterials, Crowns and Bridges and OthersSummaryGlobalData’s new report ...Read More
Nov 2012 $2500.00

  * Required field
Name *
E-mail *
Telephone 
Company *
Country *
Query 
 
   

  * Required field
Name *
E-mail *
Telephone 
Query 
 
   

Published By :  ResearchInChina

For support please
contact:
US Toll Free
+1 888-789-6604
Asia Pacific
+91-9893555190
 
 
To receive alerts about
an update, future offers and discounts on this report, signup here.
Email ID
 

Companies


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Countries


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z